Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Cervical Cancer, December 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 164 articles:
HTML format


 

Single Articles

  1. WANG J, Chen A, Chen Q, Niu H, et al
    Classifying the tumor immune microenvironment in cervical cancer based on nuclear cytoplasmic consistent genes.
    Sci Rep. 2025;15:42703.
    PubMed    
    Abstract available

  2. HAYASHI T, Abiko K, Konishi I
    CHARACTERISTIC OF MYELOID SARCOMA BY CANCER GENOME PROFILING AND ALGORITHM OF POTENTIAL BIOMARKERS FOR UTERINE MESENCHYMAL TUMOR.
    Georgian Med News. 2025;:6-13.
    PubMed    
    Abstract available

  3. CHANG X, Qu X, Ren T, Wu T, et al
    Decoding Triphenotypic Neutrophils in Cervical Cancer Evolution and Targeting SPP1+/GBP1+/ELOVL5+ Tumor-Associated Neutrophils to Sensitize Immunotherapy.
    Adv Sci (Weinh). 2025 Nov 28:e15511. doi: 10.1002/advs.202515511.
    PubMed    
    Abstract available

  4. AHMED AA
    Dual Repurposing Strategy: Rivaroxaban and Ciprofloxacin as a Synergistic Anticancer Therapy in Cervical Cancer: Insight into Inhibition of Metastasis via Targeting the EMT Pathway.
    Asian Pac J Cancer Prev. 2025;26:4195-4207.
    PubMed    
    Abstract available

  5. ABDULL RAHIM U, Mohd Yusof YA, Mustapa M, Nurdin A, et al
    Synergistic Chemopreventive Effects of Curcumin, Gingerol, and Shogaol on HeLa Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2025;26:4087-4096.
    PubMed    
    Abstract available

  6. JUNTAMONGKOL T, Siranart N, Phutinart S, Chitwarodom C, et al
    Disparities in Human Papillomavirus Vaccination and Cervical Cancer Prevention and Screening Strategies: A Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:3997-4008.
    PubMed    
    Abstract available

  7. GOUDIRA NC, Sherzai F, Petersen LK
    Cytology and high-risk human papillomavirus testing to reduce colposcopies in women with postcoital bleeding.
    Dan Med J. 2025;72:A12240920.
    PubMed    
    Abstract available

  8. HAN Y, Chen H, Song D, Li R, et al
    Evolving landscape of female cancers along with attributable risk factors in China from 1990 to 2021, and projections to 2040.
    Front Public Health. 2025;13:1629081.
    PubMed    
    Abstract available

  9. SIBARANI CNR, Suardi D, Salima S, Nathania N, et al
    Beyond the Pelvis: Brain Metastases in Cervical Cancer - A Case Series from a Low-Middle-Income Country.
    Int J Womens Health. 2025;17:4745-4753.
    PubMed    
    Abstract available

  10. CHEN C, Hu Z, Xu Q, Yuan L, et al
    Development and validation of machine learning models for assessing the risk of postoperative venous thromboembolism in cervical cancer patients.
    Sci Rep. 2025 Nov 27. doi: 10.1038/s41598-025-29761.
    PubMed    
    Abstract available

  11. TU H, Liu G, Gu H, Liu Z, et al
    Impact of treatment modality on survival in FIGO stage IIB cervical cancer: a population-based propensity-score matched analysis.
    Sci Rep. 2025;15:42280.
    PubMed    
    Abstract available

  12. THAPA S, Davies JC, Crosbie EJ, Payne K, et al
    Understanding preferences for self-sampling in a national cervical screening programme: a protocol for a discrete choice experiment.
    BMJ Open. 2025;15:e101800.
    PubMed    
    Abstract available

  13. PIETA E, Panek A, Szczepanek-Dulska M, Pogoda K, et al
    Vimentin-targeting adaptogen withaferin A: Potential to selectively suppress cervical cancer - Single-cell microspectroscopic and molecular analysis.
    Biochim Biophys Acta Mol Basis Dis. 2025 Nov 25:168125.
    PubMed    
    Abstract available

  14. FRIDSTEN S, Hellman K, Sundin A, Nedar L, et al
    Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer.
    Eur J Radiol. 2025;195:112566.
    PubMed    
    Abstract available

  15. GAO H, Qu H, Sun S, Zong L, et al
    Cervical Cancer Metastasis Presenting as Small Bowel Stricture.
    Dig Dis Sci. 2025 Nov 27. doi: 10.1007/s10620-025-09586.
    PubMed    


  16. YANG Y, Cheng S, Zhong Y, Sun P, et al
    Exploring tumor heterogeneity and drug resistance in cervical cancer through single-cell and bulk transcriptomics.
    Discov Oncol. 2025 Nov 27. doi: 10.1007/s12672-025-04037.
    PubMed    
    Abstract available

  17. CHI Y, Dong P, Zhang N, Liu B, et al
    TGM2 Regulates Radiosensitivity via POGZ-Mediated Repair of DNA Double-Strand Breaks in Cervical Cancer.
    Cancer Sci. 2025 Nov 27. doi: 10.1111/cas.70277.
    PubMed    
    Abstract available

  18. GURBUZ T, Serindag C, Onal ZE, Balik R, et al
    HPV Vaccine Recommendation Among Pediatricians: A KAP Study of Knowledge and Beliefs in Clinical Practice.
    Niger J Clin Pract. 2025;28:1130-1138.
    PubMed    
    Abstract available

  19. GUO A, Su Z, Zhang E, Lin H, et al
    Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.
    Front Immunol. 2025;16:1703032.
    PubMed    
    Abstract available

  20. SUN T, Zhao R, Zhang Y, Li D, et al
    Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies.
    Front Pharmacol. 2025;16:1699902.
    PubMed    
    Abstract available

  21. SHI L, Chen H, Zhang Z, Wang Y, et al
    Evolving HPV diagnostics: current practice and future frontiers.
    Front Cell Infect Microbiol. 2025;15:1681779.
    PubMed    
    Abstract available

  22. ZHAO H, Guo Y, Wang L, Li R, et al
    A novel disulfidptosis-related lncRNA signature to predict prognosis and immune response of cervical cancer.
    Medicine (Baltimore). 2025;104:e46023.
    PubMed    
    Abstract available

  23. JIN P, Gu C, Huang S, Liu X, et al
    Clinical pathological analysis of primary small cell neuroendocrine carcinoma of the cervix: A retrospective study.
    Medicine (Baltimore). 2025;104:e46168.
    PubMed    
    Abstract available

  24. WANG Z, Yang L, Li C, Jiang P, et al
    A bidirectional Mendelian randomization analysis of the causal relationship between immune cells and high-grade squamous intraepithelial lesion.
    Medicine (Baltimore). 2025;104:e45695.
    PubMed    
    Abstract available

  25. YANG X, Fu J, Xu Y, Li D, et al
    Photothermal Therapy Combined with Chemotherapy and Anti-Inflammation Therapy Weakens the Immunosuppression of Cervical Cancer.
    Pharmaceuticals (Basel). 2025;18:1657.
    PubMed    
    Abstract available

  26. PETRICA LA, Deacu M, Cozaru GC, Mitroi AF, et al
    Interplay Between Immune Microenvironment CD8(+) Tumor-Infiltrating Lymphocytes and PDL-1 Expression as Prognostic Markers in Invasive Cervical Squamous Cell Carcinoma.
    Medicina (Kaunas). 2025;61:2007.
    PubMed    
    Abstract available

  27. RUIZ-HERNANDEZ J, Anda-Jauregui G, Hernandez-Lemus E
    Drug Repositioning for HPV Clade-Specific Cervicouterine Cancer Using the OCTAD Pipeline.
    Int J Mol Sci. 2025;26:11238.
    PubMed    
    Abstract available

  28. RIMSKAYA E, Gorevoy A, Devyatkina A, Nazarova N, et al
    Raman Spectroscopy of Cell-Free Cervicovaginal Lavage for HPV Lesion Diagnosis: A Pilot Study.
    Int J Mol Sci. 2025;26:11064.
    PubMed    
    Abstract available

  29. GUZMAN-VENEGAS M, Moreno-Leon C, Andrade-Madrigal C, Roman A, et al
    Prevalence of Torque Teno Virus (TTV) in Cervical Precursor Lesions and Cancer in Chilean Women.
    Int J Mol Sci. 2025;26:11039.
    PubMed    
    Abstract available

  30. NYALAMBISA A, Alabi BA, Dlamini Z, Marima R, et al
    Elucidating Circular Ribonucleic Acid Mechanisms Associated with Splicing Factor 3 Inhibition in Cervical Cancer.
    Int J Mol Sci. 2025;26:10883.
    PubMed    
    Abstract available

  31. LEE YJ, Kim SY, Lee NK, Lee SW, et al
    Changes in Smoking Patterns and Cervical Cancer Risk: Preventive Implications from a Nationwide Japanese Cohort.
    Healthcare (Basel). 2025;13:2852.
    PubMed    
    Abstract available

  32. PETOUSIS S, Almperis A, Margioula-Siarkou C, Guyon F, et al
    Adjuvant Treatment for Surgically-Treated Cervical Cancer Patients: A Comprehensive Review.
    Cancers (Basel). 2025;17:3710.
    PubMed    
    Abstract available

  33. GARCIA-BARRIENTOS NT, Solorzano-Ibarra F, Klimov-Kravtchenko K, Rojas-Diaz JM, et al
    T Cell Exhaustion in the Cervical Cancer Tumor Microenvironment: PD-1 Overexpression and Co-Expression with TIGIT, Tim-3, LAG-3, and NKG2A.
    Cancers (Basel). 2025;17:3627.
    PubMed    
    Abstract available

  34. BOEMI S, Pavan M, Siena R, Lo Giudice C, et al
    Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.
    Diagnostics (Basel). 2025;15:2858.
    PubMed    
    Abstract available

  35. SENTHILKUMAR G, Pitchaimuthu R, Panneerselvam PS, Alagarswamy RP, et al
    Integrative Long Non-Coding RNA Analysis and Recurrence Prediction in Cervical Cancer Using a Recurrent Neural Network.
    Diagnostics (Basel). 2025;15:2848.
    PubMed    
    Abstract available

  36. CHEN YH, Wu JX, Yang SF, Chen TH, et al
    Cepharanthine Induces Oxidative Stress and Apoptosis in Cervical Cancer via the Nrf2/Keap1 Pathway.
    Antioxidants (Basel). 2025;14:1324.
    PubMed    
    Abstract available

  37. ASARE M, Obiri-Yeboah D, Ken-Amoah S, Akakpo PK, et al
    HPV self-sampling for cervical cancer screening among women living with HIV in Ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial.
    Trials. 2025;26:550.
    PubMed    
    Abstract available

  38. VIEIRA YP, Cesar Zoppellaro Reis R, de Araujo Versola H, Rodrigues da Cunha Fontoura M, et al
    Prevalence of mammography and cytopathological exams before and during the COVID-19 pandemic.
    BMC Womens Health. 2025;25:580.
    PubMed    
    Abstract available

  39. NDAPATANI L, Kubo E, Munene A, Odhiambo C, et al
    Cervical cancer screening and treatment of VIA positive lesions among women living with HIV in Nairobi and Kajiado counties, Kenya: results from a targeted intervention implemented under the USAID Fahari ya Jamii project in supported HIV clinics.
    BMC Womens Health. 2025 Nov 26. doi: 10.1186/s12905-025-04185.
    PubMed    
    Abstract available

  40. CHENG N, Li X, Jin Z, Liu Y, et al
    Cervical cancer screening uptake questionnaire (CCSTQ) for women: instrument development and validation.
    BMC Womens Health. 2025;25:577.
    PubMed    
    Abstract available

  41. ABATE A, Azage M
    High risk HPV among HIV positive women with normal and abnormal cervical cytology in Bahir Dar, north west Ethiopia.
    Sci Rep. 2025;15:42198.
    PubMed    
    Abstract available

  42. PAKDAMAN K, Alizadeh-Nodehi A, Lashkarbolouki AH, Esmaeilnia Shirvani A, et al
    Brain Metastases in Cervical Cancer: A Global Systematic Review and Meta-Analysis of Incidence and Clinicopathological Features.
    Cancer Rep (Hoboken). 2025;8:e70405.
    PubMed    
    Abstract available

  43. LIU W, Zhang L, Wang Y, Jiang X, et al
    Astragalus polysaccharide hinders cervical cancer immune escape by targeting NR3C2 and activating SLC40A1.
    Biochim Biophys Acta Mol Basis Dis. 2025 Nov 24:168123.
    PubMed    
    Abstract available

  44. XU Q, Deng Z, Liu J, Zhuo Y, et al
    Molecular and immune correlates of response to first-line de-escalated chemotherapy plus penpulimab and anlotinib in advanced cervical cancer.
    Cancer Discov. 2025 Nov 26. doi: 10.1158/2159-8290.CD-25-1315.
    PubMed    
    Abstract available

  45. KO K, Fukuda M, Yamanoi K, Hayashi N, et al
    Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes.
    Int J Clin Oncol. 2025 Nov 26. doi: 10.1007/s10147-025-02924.
    PubMed    
    Abstract available

  46. IRENE PARELLADA C, Siddiqui AH, Oliver E, Hughes R, et al
    Sex disparities of vaccine-preventable cancer mortality in Latin America.
    J Med Econ. 2025;28:2071-2081.
    PubMed    
    Abstract available

  47. CALVO A, Hall S, Melgar Cossich VB, Andreadakis J, et al
    HPV Vaccine Uptake and Cervical Cancer Trends in Panama: A Reference Point for Future Impact Studies.
    Vaccines (Basel). 2025;13:1173.
    PubMed    
    Abstract available

  48. DANISCH M, Postl M, Bartl T, Grimm C, et al
    Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
    J Pers Med. 2025;15:523.
    PubMed    
    Abstract available

  49. IBIS K, Durmaz M, Yanik D, Bunul I, et al
    Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy.
    Curr Oncol. 2025;32:602.
    PubMed    
    Abstract available

  50. MARTIN E, Reina G, Carlos S
    Advances in Therapeutic Vaccines Against HPV: A Review of Human Clinical Trials.
    Curr Oncol. 2025;32:600.
    PubMed    
    Abstract available

  51. SALVADOR S
    HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention.
    Curr Oncol. 2025;32:594.
    PubMed    
    Abstract available

  52. FELISI NM, Oyet D, Yung KMM, Ochola E, et al
    Barriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers and Administrators.
    Curr Oncol. 2025;32:591.
    PubMed    
    Abstract available

  53. WANG X, Chen Y, Huang J, He Q, et al
    Comparative Efficacy of Photodynamic Therapy and Cold Knife Conization for Cervical High-Grade Squamous Intraepithelial Lesions.
    Curr Oncol. 2025;32:590.
    PubMed    
    Abstract available

  54. XIE H, Huang J, Ye M, Xu J, et al
    Integrated HPV Testing, TCT, and Colposcopic VIA/VILI Improves Detection Rate for HSIL and Cervical Cancer: A Retrospective Cohort in China.
    Int J Womens Health. 2025;17:4649-4660.
    PubMed    
    Abstract available

  55. OTSUBO M, Aichi M, Kawashima Y, Yamanaka S, et al
    Malignant peritoneal mesothelioma as a secondary cancer following radiotherapy for cervical cancer: a case report and literature review.
    Gynecol Oncol Rep. 2025;62:101979.
    PubMed    
    Abstract available

  56. ALI B
    Evaluation of the Frequency and Patterns of Cervical Cancer Recurrence After Treatment Using ;18F-FDG PET-CT: A Cross-Sectional Study.
    Health Sci Rep. 2025;8:e71566.
    PubMed    
    Abstract available

  57. BOUCHHIMA N, Ammar M, Ksentini M, Zghal K, et al
    Impact of an Educational Intervention Video in HPV Prevention among Tunisian Female Students: A before-and-after Study.
    J Prev Med Hyg. 2025;66:E279-E290.
    PubMed    
    Abstract available

  58. XIONG L, Wen B, Tan D
    Analysis of the first inpatient expenditure for cervical cancer patients before and during the COVID-19 pandemic in a provincial maternal and children care hospital in China.
    BMC Res Notes. 2025;18:495.
    PubMed    
    Abstract available

  59. NUERTEY BD, Ansong J, Nartey EB, Gyimah L, et al
    Screening for cervical cancer among adult women: a self-reported nationwide study in Ghana.
    BMC Womens Health. 2025 Nov 25. doi: 10.1186/s12905-025-04180.
    PubMed    


  60. MOON TD, Salcedo MP, Mavume-Mangunyane E, Sidat M, et al
    A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mo
    BMC Public Health. 2025 Nov 25. doi: 10.1186/s12889-025-25730.
    PubMed    
    Abstract available

  61. ZHUANG S, Deng X, Fu F, Zhang Z, et al
    Mapping cellular interactions and communication landscapes in cervical cancer via single-cell transcriptomics.
    Discov Oncol. 2025 Nov 25. doi: 10.1007/s12672-025-04040.
    PubMed    
    Abstract available

  62. TRAN VT, Pham TH, Phan NKC
    Cervical image visualization and improvement for clinical support in diagnosis and treatment.
    Sci Rep. 2025;15:41732.
    PubMed    
    Abstract available

  63. WISE J
    HPV vaccine safe and reduces risk of cervical cancer, anti-misinformation review finds.
    BMJ. 2025;391:r2479.
    PubMed    


  64. SAINI V, Barman S, Pradhan S, Shinghal A, et al
    Automating IMRT planning for cervical cancer using dimension-scaled prior-based Vanilla Bayesian optimization.
    Phys Med Biol. 2025 Nov 25. doi: 10.1088/1361-6560/ae2419.
    PubMed    
    Abstract available

  65. MOSE D, Katana G, Chea SK, Ayieko P, et al
    Uptake and factors associated with cervical cancer screening among women aged 18-49 years at a public hospital in Coastal Kenya.
    PLOS Glob Public Health. 2025;5:e0004907.
    PubMed    
    Abstract available

  66. DOGHMAN I, Montero-Macias R, Malassigne V, Puech J, et al
    HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association.
    J Med Virol. 2025;97:e70720.
    PubMed    
    Abstract available

  67. HU J, Qi Z, Hu S, Xu X, et al
    Endoplasmic Reticulum Stress-Driven LncRNA Signature Predicts Cervical Cancer Prognosis and Guides Personalized Immunotherapy: A Multi-Omics and Functional Validation Study.
    Carcinogenesis. 2025 Nov 25:bgaf087. doi: 10.1093.
    PubMed    
    Abstract available

  68. PARK KT, Park JW, Jeon YJ, Bak JK, et al
    Risk of Pelvic Insufficiency Fractures in Cervical Cancer Survivors: Using the National Claim Database.
    J Korean Med Sci. 2025;40:e292.
    PubMed    
    Abstract available

  69. PAVONE M, Innocenzi C, Macellari N, Cantarini C, et al
    Assessing the Accuracy of Large Language Models on European Guidelines for Cervical Cancer: An In Silico Benchmarking Study.
    BJOG. 2025 Nov 24. doi: 10.1111/1471-0528.70095.
    PubMed    
    Abstract available

  70. ZAMANI N, Kolaei RB, Nemati F, Jouybari AD, et al
    Dose-dependent effects of wheat germ oil and vitamin E on apoptosis and gene expression in breast and cervical cancer cell lines with single-cell RNA-seq profiling.
    Sci Rep. 2025;15:41569.
    PubMed    
    Abstract available

  71. GU X, Zhang T, Yao H, Guo F, et al
    CRISPR-Cas12a-integrated pregnancy test strip biosensors: Visual detection of telomerase and miRNA let-7a in cervical cancer diagnostics.
    Biosens Bioelectron. 2025 Nov 24:118241. doi: 10.1016/j.bios.2025.118241.
    PubMed    
    Abstract available

  72. WIERENGA F, Dievert H, Chiang B, Yang H, et al
    Uptake and feasibility of HPV self-sampling among patients of a Canadian family medicine clinic.
    Can Fam Physician. 2025;71.
    PubMed    
    Abstract available

  73. GEREND MA, Wilkinson LJ, Pendleton C, Sutin AR, et al
    Weight discrimination and up-to-date breast and cervical cancer screening in US women.
    Prev Med. 2025;202:108470.
    PubMed    
    Abstract available

  74. LIU L, Zhuang S, Zheng J, Lin F, et al
    Treatment Patterns and Prognosis of Cervical Cancer Patients Aged 65 and Older: A Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18687.
    PubMed    
    Abstract available

  75. SABANAYAGAM R, Krishnamoorthy S, Balasubramanian V, Muthusami S, et al
    EGF induces SOD activity, TNF-alpha/IL-6 expression and complement regulatory proteins in cervical cancer cells: suppression by EGCG.
    Med Oncol. 2025;43:15.
    PubMed    
    Abstract available

  76. POSCHEL B, Neis KJ
    [Cervical cancer screening in Germany 2020-2022 : An analysis of the first round of screening according to the specifications of the oKFE-RL].
    Pathologie (Heidelb). 2025 Nov 24. doi: 10.1007/s00292-025-01500.
    PubMed    
    Abstract available

  77. ZOU H, Xiong W, He Y
    Single-cell and spatial transcriptome-based metabolism-immunity interaction network and therapeutic target discovery of matrine in cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed    
    Abstract available

  78. ALI N, Sykes Martin KD, Tobillo R, Meiyappan K, et al
    Risk factors and clinical outcomes of radiation-induced fistula after chemoradiation and image-guided brachytherapy for locally advanced cervical cancer.
    Gynecol Oncol Rep. 2025;62:101977.
    PubMed    
    Abstract available

  79. MAGHIMAA M
    Exploring the mechanisms of action of polyphenols in the treatment of cervical cancer.
    3 Biotech. 2025;15:430.
    PubMed    
    Abstract available

  80. HILLER GGR, Wolf B, Forberger M, Freude A, et al
    Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervix.
    Pathol Oncol Res. 2025;31:1612252.
    PubMed    
    Abstract available

  81. JIA C, Li N, Lu T, Shen X, et al
    Construction and validation of the prediction model for fear of cancer recurrence in patients with postoperative cervical cancer.
    Front Oncol. 2025;15:1670680.
    PubMed    
    Abstract available

  82. TUSAR MTT, Haq N, Gazi HR, Farazi R, et al
    Designing a Multi-Epitope Vaccine Against HPV 16, 18, 33, and 45 Targeting L1 and E7 Proteins: An Immunoinformatics Approach for Cervical Cancer Prevention and Therapy.
    Bioinform Biol Insights. 2025;19:11779322251391076.
    PubMed    
    Abstract available

  83. SOLBJOR M, Hagen M, Harstad I, Baasland I, et al
    Reflections about attendance in the Norwegian cervical cancer screening program among the youngest invited women aged 25-29 years: a qualitative interview study.
    Scand J Public Health. 2025 Nov 24:14034948251393105.
    PubMed    
    Abstract available

  84. FENG J, Shang Z, Ge B, Chu K, et al
    Analysis of the effect of dual reference lines on first positioning accuracy in intensity-modulated radiotherapy for cervical cancers.
    J Appl Clin Med Phys. 2025;26:e70342.
    PubMed    
    Abstract available

  85. LEE HS, Hong GU, Jeong W, Oh K, et al
    Information Landscape on Cervical Cancer: An Analysis of News and Online Platform Data in the Republic of Korea.
    Health Commun. 2025 Nov 24:1-19. doi: 10.1080/10410236.2025.2587893.
    PubMed    
    Abstract available

  86. HENSCHKE N, Bergman H, Buckley BS, Crosbie EJ, et al
    Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.
    Cochrane Database Syst Rev. 2025;11:CD015363.
    PubMed    
    Abstract available

  87. BERGMAN H, Henschke N, Arevalo-Rodriguez I, Buckley BS, et al
    Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.
    Cochrane Database Syst Rev. 2025;11:CD015364.
    PubMed    
    Abstract available

  88. LIBERACKA-DWOJAK M, Wilkosc-Debczynska M, Makarewicz R
    The role of perceived stress in the relationship between sexual communication, health literacy, and quality of life in women diagnosed with cervical cancer.
    Patient Educ Couns. 2025;143:109428.
    PubMed    
    Abstract available

  89. COSTA JM, Pimentel AL, Duarte I, Moreira AC, et al
    Barriers to cervical cancer screening: a cross-sectional study of non-adherent Portuguese women.
    BMC Prim Care. 2025 Nov 22. doi: 10.1186/s12875-025-03121.
    PubMed    
    Abstract available

  90. BILGE C, Kaydirak M, Gurel SN, Yurtsever D, et al
    Relationship Between HPV Vaccine Hesitancy and Attitudes Towards Early Detection of Cervical Cancer in Women of Reproductive Age.
    Enferm Clin (Engl Ed). 2025 Nov 20:502363. doi: 10.1016/j.enfcle.2025.502363.
    PubMed    
    Abstract available

  91. TONG Y, Deng W, Xu L, Li Y, et al
    A prognostic model derived from PANoptosis-associated subtypes unveils immunological features and therapeutic vulnerabilities in cervical cancer.
    Discov Oncol. 2025 Nov 22. doi: 10.1007/s12672-025-04115.
    PubMed    
    Abstract available

  92. GHOSH S, Bhatnagar P, Chabbra R
    Effect of educational intervention on knowledge of HPV and HPV vaccine and vaccine acceptability among teachers: A pilot investigation.
    Indian J Cancer. 2025;62:402-407.
    PubMed    
    Abstract available

  93. ASLAN E, Kaya Senol D, Akin Eroglu S, Turkmenoglu A, et al
    The impact of brachytherapy on sexual life in patients with gynecological cancer.
    Eur J Oncol Nurs. 2025;79:103012.
    PubMed    
    Abstract available

  94. BRUERA S, Huang Y, Bowman S, Suarez-Almazor ME, et al
    Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus.
    Lupus. 2025;34:1437-1444.
    PubMed    
    Abstract available

  95. SANLI C, Dogan Yuksekol O, Ulucan M, Baltaci N, et al
    Stigmatization and social isolation experienced by Human Papillomavirus-positive women: A phenomenological study.
    Women Health. 2025;65:749-760.
    PubMed    
    Abstract available

  96. BRYNDA D, Nemejcova K, Cibula D, Slama J, et al
    The role of HPV testing in the follow-up of patients in different clinical scenarios after diagnosis of cervical preinvasive lesions and carcinomas.
    Expert Rev Anticancer Ther. 2025;25:1405-1413.
    PubMed    
    Abstract available

  97. NARAYANAN PP S, Murugan A, Ramakrishnan J, Rajan Parasuraman Udayakumar K, et al
    Parental perspectives: a mixed method study on perceived risk, self-efficacy, vaccine response efficacy, and willingness for adolescent HPV vaccination in Puducherry, South India.
    Int J Adolesc Med Health. 2025;37:359-369.
    PubMed    
    Abstract available

  98. SILVA ADL, Marelli JGA, Lira Lopes MW, Rodrigues MT, et al
    Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome.
    Braz J Microbiol. 2025;56:2733-2742.
    PubMed    
    Abstract available

  99. DAVIES JC, Carter S, Cao J, Whittaker M, et al
    Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study.
    Br J Gen Pract. 2025;75:e853-e861.
    PubMed    
    Abstract available

  100. ACUNA MJ, Mancilla E, Acuna D, Bernal G, et al
    Prevalence of Human Papillomavirus in Arica and Antofagasta, in the north of Chile.
    Cancer Epidemiol. 2025;99:102913.
    PubMed    
    Abstract available

  101. WANG Z, Yao P, Shen S, Shao P, et al
    DMCA-Net: Dual-branch multi-granularity hierarchical contrast and cross-attention network for cervical abnormal cell detection.
    Neural Netw. 2025;192:107890.
    PubMed    
    Abstract available

  102. LIAO B, Chen L, Ruan J, Wang R, et al
    Microbiome and gartynecologic cancer.
    Cancer Lett. 2026;636:217940.
    PubMed    
    Abstract available

  103. LAI YK, Ye JF, Newcombe K, Zhao X, et al
    Empowering Unvaccinated Women with Information: How Online Cancer Information Seeking and Scanning Encourage HPV Vaccination in China.
    Health Commun. 2025;40:2985-2997.
    PubMed    
    Abstract available


  104. Screening for cervical cancer.
    CA Cancer J Clin. 2026;76:e70049.
    PubMed    


  105. PERKINS RB, Wolf AMD, Church TR, Elkin EB, et al
    Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.
    CA Cancer J Clin. 2026;76:e70041.
    PubMed    
    Abstract available

  106. RAMIREZ LVH, Forero HE, Grosso MPN, Rincon EHH, et al
    Advances in artificial intelligence for the early detection of cervical cancer in adult women: a scoping review.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo76.
    PubMed    
    Abstract available

  107. ZHANG M, Hong X, Ma N, Wei Z, et al
    Correction: the promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
    J Transl Med. 2025;23:1373.
    PubMed    


  108. SALHI I, Alzahayqa M, Qrei W, Qawasmi T, et al
    Genotypic spectrum and prevalence of HPV associated with cervical cancer in Palestine.
    BMC Infect Dis. 2025 Dec 3. doi: 10.1186/s12879-025-12276.
    PubMed    


  109. CHEN C, Zhang F, Shen J, Zheng Q, et al
    CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.
    Cell Death Discov. 2025 Dec 3. doi: 10.1038/s41420-025-02876.
    PubMed    
    Abstract available

  110. ACHILONU O, Ayeni O, Adeleke M, Mmereki D, et al
    Treatment patterns, care delays and outcomes in advanced cervical cancer: study protocol for a mixed retrospective and prospective single-centre cohort in South Africa.
    BMJ Open. 2025;15:e105299.
    PubMed    
    Abstract available

  111. CHEN Y, Zhong L, Chen J, Li X, et al
    Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting.
    Int J Biol Macromol. 2025 Dec 1:149419. doi: 10.1016/j.ijbiomac.2025.149419.
    PubMed    
    Abstract available

  112. WANG J, Hu Y, Gong J, Chen L, et al
    Nicotine Activates PI3K/AKT Pathway to Induce Cellular Proliferation, Invasion, and Migration in HPV-16 Positive Cervical Cancer SiHa Cells.
    J Appl Toxicol. 2025 Dec 3. doi: 10.1002/jat.70019.
    PubMed    
    Abstract available

  113. LAL M, K G, Nair SN, Pal UM, et al
    Design of a Flexible Silicon-based Speculum for Cervical Imaging.
    Annu Int Conf IEEE Eng Med Biol Soc. 2025;2025:1-4.
    PubMed    
    Abstract available

  114. GONG N, Takeyama S, Yamaguchi M, Urata T, et al
    Robust Papanicolaou Stain Quantification Insensitive to Imaging System Variations by Sparsity-based Stain Unmixing().
    Annu Int Conf IEEE Eng Med Biol Soc. 2025;2025:1-7.
    PubMed    
    Abstract available

  115. PARK S, Lim H, Gumel AB
    Mathematical Assessment of the Roles of Vaccination and Pap Screening on the Burden of HPV and Related Cancers in Korea.
    Bull Math Biol. 2025;87:182.
    PubMed    
    Abstract available

  116. DEMIRKAYA DB, Arslan HS, Azarkan SY
    Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models.
    Mol Biol Rep. 2025;53:159.
    PubMed    
    Abstract available

  117. ARUM A, Andreasen EK, Pedersen H, Nielsen TD, et al
    Large-Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self-Sampling Devices for At-Home Cervical Cancer Screening.
    APMIS. 2025;133:e70109.
    PubMed    
    Abstract available

  118. HUANG Y, He M, Li L, Xie R, et al
    The vaccination status and attitudes toward human papillomavirus among gynecologists in China: A cross-sectional survey.
    Hum Vaccin Immunother. 2025;21:2578902.
    PubMed    
    Abstract available

  119. ZHU Y, Xiang D, Xing H, Li Y, et al
    Nutritional and inflammatory markers for predicting delirium after radical hysterectomy for cervical cancer: development of a nomogram.
    Front Nutr. 2025;12:1644157.
    PubMed    
    Abstract available

  120. CORN E, Becht K, Adefres B, Monare B, et al
    Assessing the Clinical Utility of MRI for Preoperative Staging of Early-Stage Cervical Cancer in a Limited-Resource Setting: A Retrospective Cohort Study from Botswana.
    Res Sq [Preprint]. 2025 Nov 18:rs.3.rs-8041378. doi: 10.21203/rs.3.rs-8041378.
    PubMed    
    Abstract available

  121. HAWKES D, Saville M, Starkie R, Hassan S, et al
    Accuracy of self-collection in human papillomavirus-based cervical screening: An evidence-based review.
    Aust J Gen Pract. 2025;54:881-886.
    PubMed    
    Abstract available

  122. TROJNARSKA D, Wielgus M, Gornisiewicz K, Kot J, et al
    Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis.
    Folia Med Cracov. 2025;65:101-111.
    PubMed    
    Abstract available

  123. ONGKO EG, Budiana ING, Winata IGS, Mahendra INB, et al
    High expression of vascular endothelial growth factor is a risk factor for poor response to neoadjuvant Paclitaxel - carboplatin chemotherapy in stage IB3, IIA2, and IIB cervical cancer.
    Med J Malaysia. 2025;80:787-792.
    PubMed    
    Abstract available

  124. YANG J, Liu Q, Tang Y, Huang K, et al
    Retrospective analysis of cervical screening abnormalities in women with type 3 transformation zone without visible lesions.
    PeerJ. 2025;13:e20396.
    PubMed    
    Abstract available

  125. XU Q, He C, Zhu X, Xia Y, et al
    Deep Learning and Attention Mechanism-based Prediction of Vaginal Invasion in Early-Stage Cervical Cancer.
    Curr Med Imaging. 2025 Nov 28. doi: 10.2174/0115734056392471251103125700.
    PubMed    
    Abstract available

  126. LIU X, Liu X, Li Y, Bai S, et al
    Predictive framework for cervical cancer brachytherapy fractionation mode integrating generative model and dynamic feature aggregation GNNs.
    BMC Med Inform Decis Mak. 2025 Dec 1. doi: 10.1186/s12911-025-03294.
    PubMed    


  127. SUN Y, Chen Y, Zeng Z, Zhou B, et al
    Metal artifact reduction in spectral computed tomography for intracavity brachytherapy in cervical cancer patients: a prospective study.
    Radiat Oncol. 2025 Dec 1. doi: 10.1186/s13014-025-02767.
    PubMed    


  128. CHAUHAN R, Dagar G, Malhotra L, Gupta A, et al
    Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4.
    J Transl Med. 2025 Dec 2. doi: 10.1186/s12967-025-07442.
    PubMed    
    Abstract available

  129. HINKEL RE, Kalima M, Msadabwe SC, Mwaba CK, et al
    False-Positive Screening, Over-Referral, and Length of time between Cervical Cancer Early Detection and Confirmed Diagnosis Over Nine Years in Lusaka, Zambia.
    J Epidemiol Glob Health. 2025 Dec 1. doi: 10.1007/s44197-025-00478.
    PubMed    
    Abstract available

  130. LUGAN E, Lacorre A, Margueritte F, Ouldamer L, et al
    Locally advanced cervical cancer and para-aortic lymphadenectomy: impact of the number of removed lymph nodes, a FRANCOGYN group study.
    Eur J Surg Oncol. 2025;51:110490.
    PubMed    
    Abstract available

  131. CHOI S, Karabukayeva A, Davlyatov G, Opoku-Agyeman W, et al
    Association Between Regional Competition and Cancer Screening Rates at Federally Qualified Health Centers.
    J Ambul Care Manage. 2026;49:E40-E48.
    PubMed    
    Abstract available

  132. DONG S, Feng YN, Li XY, Du XS, et al
    Preoperative non-invasive prediction of lymph node metastasis in cervical cancer using a multiparametric radiomics model based on transvaginal ultrasound.
    Abdom Radiol (NY). 2025 Dec 1. doi: 10.1007/s00261-025-05297.
    PubMed    
    Abstract available

  133. BADINER N, Guthrie L, Stevenson E, Folkerts A, et al
    Exploratory study of a long-term hospital-based cervical cancer screening program in a high HIV prevalence area of rural Malawi.
    Gynecol Oncol Rep. 2025;62:101986.
    PubMed    
    Abstract available

  134. XIAO C, Deng J, Ren F, Zhang C, et al
    Cervical cancer burden among females under 40?years in China, Japan, and South Korea, 1990-2021: a systematic analysis for the global burden of disease study 2021.
    Front Public Health. 2025;13:1695004.
    PubMed    
    Abstract available

  135. WANG J, Bao S, Huang T, Cai Y, et al
    Fusion model combining ultrasound-based radiomics and deep transfer learning with clinical parameters for preoperative prediction of pelvic lymph node metastasis in cervical cancer.
    Front Oncol. 2025;15:1681029.
    PubMed    
    Abstract available

  136. AMAAMRI-SEEBACH T, Mobarki M, Musawi S, Peoc'h M, et al
    SATB2 is Rarely Expressed in Endometrial or Endocervical Carcinoma.
    APMIS. 2025;133:e70110.
    PubMed    
    Abstract available

  137. PASCA NM, Taut D, Greenley R, Kirkegaard P, et al
    Exploring Emotional and Cognitive Perceptions of Cervical Cancer Screening and Self-Sampling Among Vulnerable Romanian Women: A Qualitative Study.
    Health Expect. 2025;28:e70485.
    PubMed    
    Abstract available

  138. LIN Z, Zhou Y, Liu Z, Nie W, et al
    Correction: Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts.
    J Exp Clin Cancer Res. 2025;44:315.
    PubMed    


  139. NAYAB M, Elnaggar M, Asher V, Bali A, et al
    Comparative Analysis of FDG-PET Versus CT/MRI in Staging and Management of Advanced-stage Cervical Cancer.
    Anticancer Res. 2025;45:5503-5511.
    PubMed    
    Abstract available

  140. DAO THL, Nakamura K, Okamoto K, Vu TH, et al
    Leucine-rich Repeat-containing 15 as a Potential Marker and Therapeutic Target in Cervical Cancer.
    Anticancer Res. 2025;45:5409-5421.
    PubMed    
    Abstract available

  141. PAWAR M, Pingale S, Kadam K, Jadhav A, et al
    Artificial intelligence-driven screening, early diagnosis, and treatment strategies for cervical cancer: an overview.
    Infect Agent Cancer. 2025 Nov 28. doi: 10.1186/s13027-025-00716.
    PubMed    


  142. KALULU P, Olusanya OA, Salako A, Obodoechina N, et al
    Participatory implementation science to enhance knowledge and build the capacity to increase the uptake and sustainability of HPV vaccination among girls in Nigeria.
    J Health Popul Nutr. 2025;44:416.
    PubMed    
    Abstract available

  143. KUMAR P, Bateson D, Costa T, Ahmed S, et al
    HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review.
    Vaccine. 2025;68:127968.
    PubMed    
    Abstract available

  144. ANDOH J, Taghavi K, Moono M, Basu P, et al
    Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia.
    HIV Med. 2025 Nov 5. doi: 10.1111/hiv.70134.
    PubMed    
    Abstract available

  145. AVILA E, Mendez-Perez EA, Diaz L, Garcia-Quiroz J, et al
    Vasculogenic mimicry in human cancers associated with chronic high-risk human papillomavirus infection.
    Future Oncol. 2025;21:3677-3689.
    PubMed    
    Abstract available

  146. GAUTAM P, Zhao J, Levi C, Raman S, et al
    Potential Protective Effect of Statins against High-Grade Squamous Intraepithelial Lesions in Women with Metabolic Comorbidities.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2169-2177.
    PubMed    
    Abstract available

  147. DESIEGHARDT A, Ding L, Ermel A, Franco EL, et al
    Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction.
    JAMA Pediatr. 2025;179:1326-1334.
    PubMed    
    Abstract available

  148. RATTANAPITOON NK, Padchasuwan NH, La N, Rattanapitoon SK, et al
    Beyond virtual learning: Leveraging project ECHO to sustain and localize national cancer control plan implementation in LMICs.
    J Cancer Policy. 2025;46:100638.
    PubMed    
    Abstract available

  149. CHU H, Liu S
    Generating targeted and tailored health communication narratives with AI.
    Risk Anal. 2025;45:3505-3518.
    PubMed    
    Abstract available

  150. PANG L, He P, Han Y, Cui H, et al
    Semantic Consistency Network with Edge Learner and Connectivity Enhancer for Cervical Tumor Segmentation from Histopathology Images.
    Interdiscip Sci. 2025;17:917-934.
    PubMed    
    Abstract available

  151. YUILL S, Smith MA, Velentzis LS, Nisha M, et al
    Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage Analysis.
    Aust N Z J Obstet Gynaecol. 2025;65:518-529.
    PubMed    
    Abstract available

  152. DELLI CARPINI G, Mammadov Z, Leeson S, Hammer A, et al
    The effect of healthcare disruptions during the COVID-19 pandemic on colposcopy services and practice: A systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2025;104:2215-2225.
    PubMed    
    Abstract available

  153. FRAYLE H, Gori S, Pagan A, Solda M, et al
    Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy.
    Int J Cancer. 2026;158:587-596.
    PubMed    
    Abstract available

  154. BAI F, Wu G, Qu X, Shen J, et al
    Optimal adjuvant radiotherapy strategy for cervical cancer: a multi-center database cohort study.
    Int J Gynecol Cancer. 2025;36:102791.
    PubMed    
    Abstract available

  155. SIGNORELLI M, Secchi M
    Correspondence on "Clinical outcomes of external radiotherapy boost versus no boost to radiologically positive lymph nodes in FIGO stage IIIC cervical cancer" by Karthik S Rishi et al.
    Int J Gynecol Cancer. 2025 Nov 4:102777. doi: 10.1016/j.ijgc.2025.102777.
    PubMed    


  156. TSEGAYE AT, Clarke MA, Long B, Chappell NP, et al
    Performance of the Alinity m HR HPV assay on self-collected vaginal samples compared to clinician-collected cervical samples.
    J Clin Virol. 2025;181:105883.
    PubMed    
    Abstract available

  157. MARTINELLI M, Hassan SS, Yilmaz E, Lagheden C, et al
    Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values.
    J Clin Virol. 2025;181:105869.
    PubMed    
    Abstract available

  158. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
    [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
    Oncol Rep. 2026;55:23.
    PubMed    
    Abstract available

  159. ZIMMERMANN L, Knausl B, Knoth J, Sturdza A, et al
    Diffusion weighted imaging for gross tumor volume delineation in primary radiochemotherapy and image guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2025;214:111306.
    PubMed    
    Abstract available

  160. PAN J, Wei W, Dai B, Wang Y, et al
    Restricted spectrum imaging and diffusion kurtosis imaging for assessing lymph node metastasis in cervical cancer: a histogram analysis-based study.
    BMC Cancer. 2025;25:1817.
    PubMed    
    Abstract available

  161. SU R, Yang D, Chen S, Ding X, et al
    Impact of laparoscopic surgical proficiency on survival outcomes in laparoscopic radical hysterectomy for cervical cancer: a multi-center cohort study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15220.
    PubMed    
    Abstract available

  162. ZHAI X, Kong T, Yang X, Yu J, et al
    Clinical performance of triage strategies for HPV-positive women in cervical cancer screening in rural Yunnan China.
    BMC Cancer. 2025 Dec 3. doi: 10.1186/s12885-025-15375.
    PubMed    
    Abstract available

  163. XU L, Guo R, Tang F, Sun X, et al
    Dosimetric analysis of plans using x-ray and gamma-ray combination strategy for advanced cervical cancer patients with pelvic lymph node metastasis.
    BMC Cancer. 2025;25:1836.
    PubMed    
    Abstract available

  164. HAN T, Deng S
    Prevalence and genotype distribution of Human Papillomavirus (HPV) among 14,110 women in Anqing urban area: A population-based cross-sectional survey.
    PLoS One. 2025;20:e0336959.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;